PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

Breast cancer is the most common cancer type among women worldwide. The majority of breast cancer expresses estrogen receptor (ER) and endocrine therapy is a standard treatment of ER-positive breast cancer. However, development of the therapy resistance is still a major challenge and thus new therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeiwa, Toshihiko, Ikeda, Kazuhiro, Suzuki, Takashi, Sato, Wataru, Iino, Kaori, Mitobe, Yuichi, Kawabata, Hidetaka, Horie, Kuniko, Inoue, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184599/
https://www.ncbi.nlm.nih.gov/pubmed/35681031
http://dx.doi.org/10.1038/s41598-022-13601-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184599/
https://www.ncbi.nlm.nih.gov/pubmed/35681031
http://dx.doi.org/10.1038/s41598-022-13601-7

Ejemplares similares